RxDoctor Payments Data

John Rasor, DO

Family Medicine · Howell, MINPI 1124089800

Payments from drug & device makers

$699in general payments, 2019–2025

Across 55 payments — averaging $12.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$128
  • AstraZeneca$89
  • Amgen$66
  • Takeda Pharmaceuticals U.S.A., Inc.$62
  • Teva Pharmaceuticals USA, Inc.$50
  • AbbVie$48
  • plus $256 from 10 others

What the payments were for

  • Food & beverage$699100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$699 in reported general payments places this provider in the 65th percentile of 3,945 family medicine providers in Michigan.

See all family medicine providers in Michigan

Medicare billing

Part B allowed, 2024
$42,772
Medicare patients
126
Services billed
622

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban63$87,577
TrulicityDulaglutide41$63,125
Trelegy ElliptaFluticasone/Umeclidin/Vilanter57$56,573
XareltoRivaroxaban44$51,866
JardianceEmpagliflozin38$46,784
OzempicSemaglutide16$33,602
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl157$29,719
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr32$25,271
JanuviaSitagliptin Phosphate27$17,549
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog18$15,151
Fluticasone-SalmeterolFluticasone Propion/Salmeterol62$12,585
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog21$9,241
Albuterol Sulfate HfaAlbuterol Sulfate258$7,380
Lantus SolostarInsulin Glargine,hum.Rec.Anlog29$7,324
Buprenorphine15$6,619

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Paxlovid$29$89,00674 claims
Lilly USA, LLCTrulicity$34$63,12541 claims
Boehringer IngelheimJardiance$23$46,78438 claims
Novo NordiskOzempic$128$33,60216 claims
MerckJanuvia$14$17,54927 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 3,945 family medicine providers in Michigan.

Other family medicine in Howell

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →